Clinical Trial Update: Allogenic Stem Cell Transplantation (SCT) With Non-myeloablative Conditioning in Patients With Relapse Non-Hodgkin's Lymphoma (NHL) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating allogeneic stem cell transplantation with non-myeloablative conditioning in patients with relapsed non-Hodgkin lymphoma; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | Conditions: Non-Hodgkin Lymphoma | Phase 2 | Status: COMPLETED